Nounou, M. I., Adkins, C. E., Rubinchik, E., Terrell-Hall, T. B., Afroz, M., Vitalis, T., . . . Lockman, P. R. (2016). Anti-cancer antibody trastuzumab-melanotransferrin conjugate (BT2111) for the treatment of metastatic HER2+ breast cancer tumors in the brain: An in-vivo study. Pharm Res.

Nounou, Mohamed Ismail, Chris E. Adkins, Evelina Rubinchik, Tori B. Terrell-Hall, Mohamed Afroz, Tim Vitalis, Reinhard Gabathuler, Mei Mei Tian, and Paul R. Lockman. "Anti-cancer Antibody Trastuzumab-melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: An In-vivo Study." Pharm Res 2016.

Nounou, Mohamed Ismail, et al. "Anti-cancer Antibody Trastuzumab-melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: An In-vivo Study." Pharm Res 2016.